Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

337.986
-4.672-1.36%
Number of Gainers:13
Number of Losers:34
Number of Flat:12
PE:- -
High:342.639
Open:342.639
Low:337.222
Close:342.657
Volume:127.89M
Turnover:3.51B
Market Cap:802.77B
Float Cap:697.68B

Loading ...

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Reuters
·
Aug 20

Zylox-Tonbridge FY26 H1 Profit Climbs 47.8% to RMB 179.1 Million; Revenue Rises 31.1% to RMB 632.04 Million

Reuters
·
Aug 20

Zylox-Tonbridge Medical Technology H1 Net Income RMB 179.11 Million

THOMSON REUTERS
·
Aug 20

Zephirin Upgrades Baidu to Hold from Sell, Adjusts Price Target to HK$115 from HK$92

MT Newswires Live
·
Aug 20

Dow Jones Top Company Headlines at 7 am ET: Alibaba Posts Weaker Earnings Amid Heavy AI Investments | Deere's ...

Dow Jones
·
Aug 20

Historic Breakthrough in mRNA Cancer Vaccines: E Fund Biotech ETF (03186) Taps Innovation Opportunities Across Hong Kong and US Markets

Stock News
·
Aug 20

China's Baidu Says Apollo Go Autonomous Vehicles Officially Available on Uber in Dubai

Reuters
·
Aug 20

Uber Launches Baidu’s Fully Driverless Apollo Go in Dubai, Establishing the First Multi-Partner Autonomous Network Globally

THOMSON REUTERS
·
Aug 20

Auto Sector Shares Surge as Export Volumes Stay Above One Million for Two Consecutive Months, Chengdu Motor Show Approaches

Stock News
·
Aug 20

KEYMED BIO-B Surges Over 6% Pre-Market as H1 Drug Sales Climb 132%

Deep News
·
Aug 20

KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing

Stock News
·
Aug 19

Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market

Reuters
·
Aug 19

KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026

THOMSON REUTERS
·
Aug 19

KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing

THOMSON REUTERS
·
Aug 19

Keymed Biosciences Swings to FY26 H1 Profit of RMB 1.22 Billion; Revenue Rises 24% to RMB 617.07 Million

Reuters
·
Aug 19

KeyMed Biosciences H1 Revenue RMB 617.068 Million

THOMSON REUTERS
·
Aug 19

CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses

Simply Wall St.
·
Aug 19

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares

Reuters
·
Aug 19

Jefferies Adjusts Baidu's Price Target to HK$163 From HK$170, Keeps at Buy

MT Newswires Live
·
Aug 19

Li Auto Inc. Spends $3.89 Million on Share Buyback on August 18

Stock News
·
Aug 19